Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.
about
The prion hypothesis in Parkinson's disease: Braak to the futureVisual signs and symptoms of Parkinson's diseaseInterface between tauopathies and synucleinopathies: A tale of two proteinsHow does parkin ligate ubiquitin to Parkinson's disease?The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's DiseaseParkin Regulation and Neurodegenerative DisordersThe genetics and neuropathology of Parkinson's diseaseGenetics in Parkinson disease: Mendelian versus non-Mendelian inheritanceLewy bodies and parkinsonism in families with parkin mutationsβ-amyloid triggers ALS-associated TDP-43 pathology in AD modelsParkin disease: a clinicopathologic entity?Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function.The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.How much phenotypic variation can be attributed to parkin genotype?The pallidopyramidal syndromes: nosology, aetiology and pathogenesis.Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.Glial cell inclusions and the pathogenesis of neurodegenerative diseasesPathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.Genetics of parkinsonism.Genetic neuropathology of Parkinson's disease.Genotype-phenotype correlation: familial Parkinson disease.Diagnostic considerations in juvenile parkinsonism.Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase ParkinA Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristicsGenetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories.Parkinson's disease: the genetics of a heterogeneous disorder.Cell therapy for Parkinson's disease: only young onset patients allowed? Reflections about the results of recent clinical trials with cell therapy and the progression of Parkinson's disease.α-Synuclein oligomers and clinical implications for Parkinson disease.Update on the genetics of Parkinson's disease.Parkin disease and the Lewy body conundrumWhat determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?Complicated recessive dystonia parkinsonism syndromes.The multiple mechanisms of amyloid deposition: the role of parkin.Molecular pathology of Lewy body diseases.A critical evaluation of the ubiquitin-proteasome system in Parkinson's diseaseMolecular pathogenesis of Parkinson disease: insights from genetic studies.The role of parkin in familial and sporadic Parkinson's disease.
P2860
Q22001062-A7F46EE5-BDCD-4FE3-9ABE-FC5131F8043EQ22242419-53AE73C9-11E1-455F-A1F6-AC394431C007Q22252940-DB74B1EF-DAB6-4A44-8146-0C086F9AB61DQ24537156-DBF73E7A-8839-47A2-9E30-0DFEA142C5D6Q26744716-35F4EDCC-1B75-44B7-9985-30E38DD5F144Q26770443-5D16514C-E158-41CF-869B-BD46CD7F0D07Q26859945-75D1D7B8-6CF7-4DCB-8F65-74663172328FQ28077356-BEB2F5FD-013F-4629-89D5-F5E7AC4B487DQ28216308-7BF42571-C787-4FB9-8709-9C9841FD5BE4Q28580544-4001EA53-0E5B-48A4-964D-B33C5051B967Q30594306-975DD05E-B9CE-4B3D-8791-95BC395533BFQ33202814-6E2AACBA-1E57-446B-835F-66BA7DC046CCQ33203763-2980C599-C5F6-41D8-8AE8-B840CB5BB637Q33222986-94A598C6-E90C-4B9A-A5B9-28BB98EF9E00Q33909482-7B04DB2E-1C7B-442A-8A45-B7E8DBA3CCB7Q34218728-975FDE8C-69ED-4D62-BE5F-986A07D3C9E6Q34336776-90F0D44D-83C4-4BB4-AAB2-440D5CD50953Q34528753-DD62E442-2C82-4BFB-93BA-380E654E4A56Q34538330-41204759-E675-4299-AE7B-0993D0967607Q34612168-051A8BE0-01CE-4E2B-818F-DC749F01DC80Q34811944-047FBDB6-DA06-4A6F-AA65-7A6577DDAF00Q34825312-6CA599C9-6ED4-4BCC-9072-9C92B14021ACQ35117826-671BF7D3-73C5-4183-955B-9878D31FA98BQ35673290-2263443C-59B3-458E-8526-4AF53FAF8ACBQ35748069-C23B81BC-7475-485D-AED8-8FC5445F4DD5Q35888058-48896720-0850-481B-91CF-C8B4EB004696Q35924508-F126D123-4B43-41F4-AD73-EE20D71909DAQ36359548-ED46DFCF-E2D2-402E-83EB-004A51A956CCQ36516918-95E3AC7B-38A0-409C-B310-7D9B23CAE5F2Q36660994-F9945B01-1552-47E7-BD43-F18583D226D1Q36718306-E762A05F-A542-4D6C-9A7F-3DBDC52B74ACQ37050631-B27FD13F-E06A-4F72-9C88-6256A55585D9Q37086050-8B592268-ECA1-4E3B-A36D-F876441A8943Q37146578-F6034E49-F308-4C89-A190-E6B8BB154586Q37382475-2841AF72-88F3-4093-A8E8-7C20D00A4A8BQ37409163-9EB12614-B059-45A0-9182-650CAACF8765Q37462203-576F6087-FAEC-4C40-86C9-F9570C2046E0Q37472304-DC199E1B-A8C8-4A92-89E6-116A2C03A4ACQ37561699-CCADB092-4553-4A84-9888-5B50F937F36DQ37699215-1597302A-8BC8-41C3-90F8-896E795DDDD2
P2860
Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Clinical and pathologic abnorm ...... ism and parkin gene mutations.
@en
Clinical and pathologic abnorm ...... ism and parkin gene mutations.
@nl
type
label
Clinical and pathologic abnorm ...... ism and parkin gene mutations.
@en
Clinical and pathologic abnorm ...... ism and parkin gene mutations.
@nl
prefLabel
Clinical and pathologic abnorm ...... ism and parkin gene mutations.
@en
Clinical and pathologic abnorm ...... ism and parkin gene mutations.
@nl
P2093
P356
P1433
P1476
Clinical and pathologic abnorm ...... ism and parkin gene mutations.
@en
P2093
B P van de Warrenburg
C B Lücking
M W Horstink
P Praamstra
P Wesseling
P304
P356
10.1212/WNL.56.4.555
P407
P577
2001-02-01T00:00:00Z